Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV
The role of the thymus in HIV infection: a 10 year perspective
CCR5 or CXCR4 use influences the relationship between CD4 cell depletion, NKp44L expression and NK cytotoxicity in SHIV-infected macaques
Maternal Herpes simplex virus type 2 infection, syphilis and risk of intra-partum transmission of HIV-1: results of a case control study
Intrahepatic mRNA expression in hepatitis C virus and HIV/hepatitis C virus co-infection: infiltrating cells, cytokines, and influence of HAART
Differences in proviral DNA load between HIV-1- and HIV-2-infected patients
NKG2C is a major triggering receptor involved in the Vδ1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells
Zidovudine/lamivudine contributes to insulin resistance within 3 months of starting combination antiretroviral therapy
Fixed duration interruptions are inferior to continuous treatment in African adults starting therapy with CD4 cell counts < 200 cells/μl
Pharmacokinetics, safety and efficacy of lopinavir/ritonavir in infants less than 6 months of age: 24 week results
Asymptomatic myocardial ischaemia in HIV-infected adults
Can response of a pruritic papular eruption to antiretroviral therapy be used as a clinical parameter to monitor virological outcome?
Efficacy and tolerability of long-term efavirenz plus nucleoside reverse transcriptase inhibitors for HIV-1 infection
Population prevalence of reported and unreported HIV and related behaviors among the household adult population in New York City, 2004
Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort
Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy
HIV dynamics and immunosenescence
Combination antiretroviral therapy failure and HIV super-infection
Prevalence and impact of HIV-1 protease mutation L76V on lopinavir resistance
Stopping antiretroviral therapy: role for therapeutic drug monitoring
Preventable zidovudine overdose during postnatal prophylaxis in healthy children born to HIV-1-positive mothers
Initial spontaneous clearance and re-infection with a distinct hepatitis C virus genotype leading to chronic hepatitis C in an HIV+ intravenous drug user
An important, but not the first, hepatitis C virus behavioural intervention study
An important, but not the first, hepatitis C virus behavioural intervention study: authors' reply
Comment on Neumann et al. ‘Differential antiviral effect of PEG-interferon-alpha-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients’
Representative sampling and analysis in HIV molecular epidemiology studies
Withdrawal of Pneumocystis prophylaxis
Withdrawal of Pneumocystis prophylaxis: authors' reply